stockrowRepligen Corporation
RGEN Healthcare Medical Instruments & Supplies
Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.
- Revenue
- +10.9%
- EPS
- −351.9%
- Free cash flow
- −11.5%
- Total debt
- +3.28%
Quarter to September 2026, against a year earlier
Follow RGEN
Alert me
Repligen Corporation (RGEN) Free cash flow
Repligen Corporation's free cash flow for fiscal 2025 was $91.9M, down 35.5% from $142.5M in fiscal 2024. Over the twelve months to 30 September 2026 it was $105.5M. Over the past ten years it has ranged from $3.2M (fiscal 2016) to $142.5M (fiscal 2024); the current reading is higher than 91% of that period. Repligen Corporation ranks 18th of 51 Medical Instruments & Supplies companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $91.9M | (35.49%) |
| FY2024 | $142.5M | 90.16% |
| FY2023 | $74.9M | 93.43% |
| FY2022 | $38.7M | (18.86%) |
| FY2021 | $47.7M | 31.58% |
| FY2020 | $36.3M | (17.66%) |
| FY2019 | $44.1M | 135.21% |
| FY2018 | $18.7M | 56.15% |
| FY2017 | $12.0M | 270.16% |
| FY2016 | $3.2M | (73.92%) |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $37.8M | 41.65% |
| Jun 2026 | $26.7M | 14.34% |
| Mar 2026 | $23.3M | 32.73% |
| Dec 2025 | $17.6M | (58.82%) |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| BAX Baxter International Inc. compare | $1.1B |
| ALGN Align Technology, Inc. compare | $749.9M |
| COO The Cooper Companies, Inc. compare | $678.0M |
| AVTR Avantor, Inc. compare | $439.2M |
| ATR AptarGroup, Inc. compare | $295.0M |
| BLCO Bausch + Lomb Corporation compare | $252.0M |
| RGEN Repligen Corporation | $105.5M |
| TFX Teleflex Incorporated compare | $53.1M |
| SOLV Solventum Corporation compare | $0.00 |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on RGEN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement